From functional genomics to functional immunomics: New challenges, old problems, big rewards

PLoS Computational Biology

Volumn 2, Issue 7, 2006, Pages 0651-0662

  Braga Neto, Ulisses M ^a   Marques, Ernesto T A ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; EPITOPES; GENES; MICROARRAYS; VACCINES; VIRUSES;

AUTOIMMUNE DISEASE; BIOLOGICAL MARKERS; DNA MICROARRAY TECHNOLOGY; FUNCTIONAL GENOMICS; IMMUNOLOGICAL RESPONSE; LARGE-SCALES; MEASUREMENTS OF; MICROARRAY TECHNOLOGIES; SCIENTIFIC DISCIPLINE; VIRAL INFECTIONS;

T-CELLS;

BIOLOGICAL MARKER; PROTEOME;

ALLERGY; AUTOIMMUNE DISEASE; DIABETES MELLITUS; DNA MICROARRAY; ENZYME LINKED IMMUNOSPOT ASSAY; FUNCTIONAL GENOMICS; HUMAN IMMUNODEFICIENCY VIRUS; INFLUENZA; REVIEW; VIRUS INFECTION; BIOTECHNOLOGY; EPITOPE MAPPING; FORECASTING; GENOMICS; IMMUNOLOGY; METHODOLOGY; MICROARRAY ANALYSIS;

HUMAN IMMUNODEFICIENCY VIRUS;

BIOTECHNOLOGY; EPITOPE MAPPING; FORECASTING; GENOMICS; MICROARRAY ANALYSIS; PROTEOME;

EID: 33746642628     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.0020081     Document Type: Review

References (118)

1. Schena M, Shalon D, Davis RW, Brown PO (1995) Quantitative monitoring of gene expression patterns via a complementary DNA microarray. Science 270: 467-470.
2. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, et al. (1996) Expression monitoring by hybridization to high-density oligonucleotide arrays. Nature Biotechnol 14: 1675-1680.
3. Chen Y, Dougherty E, Bittner M (1997) Ratio-based decisions and the quantitative analysis of cDNA microarray images. J Biomed Opt 2: 364-374.
4. Kohane IS, Kho A, Butt AJ (2002) Microarrays for an integrative genomics. Cambridge (Massachusetts): The MIT Press. 326 p.
5. Bryant PA, Venter D, Robins-Browne R, Curtis N (2004) Chips with everything: DNA microarrays in infectious diseases. Lancet Infect Dis 4: 100-111.
6. Fahrer A, Bazan J, Papathanasiou P, Nelms K, Goodnow C (2001) A genomic view of immunology. Nature 409: 836-838.
7. Sette A, Fleri W, Peters B, Sathiamurthy M, Bui HH, et al. (2005) A roadmap for the immunomics of category A-C pathogens. Immunity 22: 155-161.
8. Brusic V (2003) From immunoinformatics to immunomics. J Bioinform Comput Biol 1: 179-181.
9. Soen Y, Chen DS, Kraft DL, Davis MM, Brown PO (2003) Detection and characterization of cellular immune responses using peptide-MHC microarrays. PLoS Biol 1: 429-438. DOI: 10.1371/journal.pbio.0000065
10. Quintana FJ, Hagedorn PH, Elizur G, Merbl Y, Domany E, et al. (2004) Functional immunomics: Microarray analysis of IgG autoantibody repertoires predicts the future response of mice to induced diabetes. Proc Natl Acad Sci U S A 101: 14615-14621.
11. Stone JD, Demkowicz WE Jr, Stern LJ (2005) HLA-restricted epitope identification and detection of functional T cell responses by using MHC-peptide and costimulatory microarrays. Proc Natl Acad Sci U S A 102: 3744-3749.
12. Mezzasoma L, Bacarese-Hamilton T, Di Cristina M, Rossi R, Bistoni F, et al. (2002) Antigen microarrays for serodiagnosis of infectious diseases. Clin Chem 48: 121-130.
13. Neuman de Vegvar HE, Robinson WH (2004) Microarray profiling of antiviral antibodies for the development of diagnostics, vaccines, and therapeutics. J Clin Immunol 111: 196-201.
14. De Groot AS (2004) Immunome-derived vaccines. Expert Opin Biol Ther 4: 767-772.
15. Brusic V, August JT (2004) The changing field of vaccine development in the genomics era. Pharmacogenomics 5: 597-600.
16. The Genome International Sequencing Consortium (2001) Initial sequencing and analysis of the human genome. Nature 409: 860-921.
17. Durbin R, Eddy SR, Krogh A, Mitchison G (1999) Biological sequence analysis. Cambridge (United Kingdom): Cambridge University Press. 368 p.
18. Benson DA, Karsch-Mizrachi I, Lipman DJ, Wheeler DL (2003) GenBank. Nucleic Acids Res 31: 23-27.
19. Kalyuzhny AE, editor (2005) Handbook of ELISPOT: Methods and protocols. Totowa (New Jersey): Humana Press. 321 p.
20. Givan AL (2001) Flow cytometry: First principles. 2nd edition. New York: Wiley-Liss. 273 p.
21. Peters B, Sidney J, Bourne P, Bui HH, Buus S, et al. (2005) The immune epitope database and analysis resource: From vision to blueprint. PLoS Biol 3: DOI: 10.1371/journal.pbio.0030091
22. Peters B, Sidney J, Bourne P, Bui HH, Buus S, et al. (2005) The design and implementation of the immune epitope database and analysis resource. Immunogenetics 57: 326-336.
23. Van Regenmortel MH (2001) Antigenicity and immunogenicity of synthetic peptides. Biologicals 29: 209-213.
24. Moreau V, Granier C, Villard S, Laune D, Molina F (2006) Discontinuous epitope prediction based on mimotope analysis. Bioinformatics 22: 1088-1095.
25. Nyarady Z, Czompoly T, Bosze S, Nagy G, Petrohai A, et al. (2006) Validation of in silico prediction by in vitro immunoserological results of fine epitope mapping on citrate synthase specific autoantibodies. Mol Immunol 43: 830-838.
26. Rammennsee HG, Friede T, Stevanovic S (1995) MHC ligands and peptide motifs: First listing. Immunogenetics 41: 178-228.
27. Brusic V, Rudy G, Honeyman M, Hammer J, Harrison L (1998) Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network. Bioinformatics 14: 121-130.
28. Bian H, Reidhaar-Olson JF, Hammer J (2003) The use of bioinformatics for identifying class II-restricted T-cell epitopes. Methods 29: 299-309.
29. Sung MH, Simon R (2004) Candidate epitope identification using peptide property models: Application to cancer immunotherapy. Methods 34: 460-467.
30. Guan P, Doytchinova IA, Zygouri C, Flower DR (2003) MHCPred: Bringing a quantitative dimension to the online prediction of MHC binding. J Appl Bioinformatics 2: 63-66.
31. Petrovsky N, Silva D, Brusic V (2003) The future for computational modelling and prediction systems in clinical immunology. Novartis Found Symp 254: 23-32.
32. Zhang GL, Khan AM, Srinivasan KN, August JT, Brusic V (2005) MULTIPRED: A computational system for prediction of promiscuous HLA binding peptides. Nucleic Acids Res 33: W172-W179.
33. Srinivasan KN, Zhang GL, Khan AM, August JT, Brusic V (2004) Prediction of class I T-cell epitopes: Evidence of presence of immunological hot spots inside antigens. Bioinformatics 20: I297-I302.
34. Brusic V, Petrovsky N, Zhang G, Bajic VB (2002) Prediction of promiscuous peptides that bind HLA class I molecules. Immunol Cell Biol 80: 280-285.
35. Zhang GL, Srinivasan KN, Veeramani A, August JT, Brusic V (2005) PREDBALB/c: A system for the prediction of peptide binding to H2d molecules, a haplotype of the BALB/c mouse. Nucleic Acids Res 33: W180-W183.
36. Larsen MV, Lundegaard C, Lamberth K, Buus S, Brunak S, et al. (2005) An integrative approach to CTL epitope prediction: A combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions. Eur J Immunol 35: 2295-2303.
37. Nielsen M, Lundegaard C, Worning P, Lauemoller SL, Lamberth K, et al. (2003) Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci 12: 1007-1017.
38. Nielsen M, Lundegaard C, Worning P, Hvid CS, Lamberth K, et al. (2004) Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach. Bioinformatics 20: 1388-1397.
39. Bian H, Hammer J (2004) Discovery of promiscuous HLA-II-restricted T cell epitopes with TEPITOPE. Methods 34: 468-475.
40. Christensen JK, Lamberth K, Nielsen M, Lundegaard C, Worning P, et al. (2003) Selecting informative data for developing peptide-MHC binding predictors using a query by committee approach. Neural Comput 15: 2931-2942.
41. Meister GE, Roberts CG, Berzofsky JA, De Groot AS (1995) Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences. Vaccine 13: 581-591.
42. Tenzer S, Peters B, Bulik S, Schoor O, Lemmel C, et al. (2005) Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I binding. Cell Mol Life Sci 62: 1025-1037.
43. Lund O, Nielsen M, Kesmir C, Petersen AG, Lundegaard C, et al. (2004) Definition of supertypes for HLA molecules using clustering of specificity matrices. Immunogenetics 55: 797-810.
44. Margalit H, Spouge JL, Cornette JL, Cease KB, Delisi C, et al. (1987) Prediction of immunodominant helper T cell antigenic sites from the primary sequence. J Immunol 138: 2213-2229.
45. De Groot AS, Rappuoli R (2004) Genome-derived vaccines. Expert Rev Vaccines 3: 59-76.
46. Peters B, Tong W, Sidney J, Sette A, Weng Z (2003) Examining the independent binding assumption for binding of peptide epitopes to MHC-I molecules. Bioinformatics 19: 1765-1772.
47. Peters B, Bui HH, Frankild S, Nielsen M, Lundegaard C, et al. (2006) A community resource benchmarking predictions of peptide binding to MHC-I molecules. PLoS Comput Biol 2: DOI: 10.1371/journal.pcbi.0020065
48. Wang Y (2004) Immunostaining with dissociable antibody microarrays. Proteomics 4: 20-26.
49. Delehanty JB, Shaffer KM, Lin B (2004) Transfected cell microarrays for the expression of membrane-displayed single-chain antibodies. Anal Chem 76: 7323-7328.
50. Schwenk JM, Stoll D, Templin MF, Joos TO (2002) Cell microarrays: An emerging technology for the characterization of antibodies. BioTechniques 33: S54-S61.
51. Janzi M, Ödling J, Pan-Hammarström Q, Sundberg M, Lundeberg J, et al. (2005) Serum microarrays for large scale screening of protein levels. Mol Cell Proteomics 4: 1942-1947.
52. Borràs E, Martin R, Judkowski V, Shukaliak J, Zhao Y, et al. (2002) . (2002) J Immunol Methods 267: 79-97.
53. Nino-Vasquez JJ, Allicotti G, Borràs E, Wilson DB, Valmori D, et al. (2004) A powerful combination: The use of positional scanning libraries and biometrical analysis to identify cross-reactive T cell epitopes. Mol Immunol 40: 1063-1074.
54. Sahin U, Tureci O, Pfreundschuh M (1997) Serological identification of human tumor antigens. Curr Opin Immunol 9: 709-716.
55. Lee SY, Williamson B, Caballero OL, Chen YT, Scanlan MJ, et al. (2004) Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancer. Cancer Immunity 4: 13.
56. Vaughn HA, St Clair F, Scanlan MJ, Chen E, Maraskovsky A, et al. (2004) The humoral immune response to head and neck cancer antigens as defined by the serological analysis of tumor antigens by recombinant cDNA expression cloning. Cancer Immunity 4: 5.
57. Lee S-Y, Obata Y, Yoshida M, Stockert E, Williamson B, et al. (2003) Immunomic analysis of human sarcoma. Proc Natl Acad Sci U S A 100: 2651-2656.
58. Old LJ, Chen YT (1998) New paths in human cancer serology. J Exp Med 187: 1163-1167.
59. Angenendt P, Glokler J, Murphy D, Lehrach H, Cahill DJ (2002) Toward optimized antibody microarrays: A comparison of current microarray support materials. Anal Biochem 309: 253-260.
60. Kusnezow W, Hoheisel JD (2003) Solid supports for microarray immunoassays. J Mol Recognit 16: 165-176.
61. Delehanty JB (2004) Printing functional protein microarrays using piezoelectric capillaries. Methods Mol Biol 264: 135-143.
62. Olle EW, Sreekumar A, Warner RL, McClintock SD, Chinnaiyan AM, et al. (2005) Development of an internally controlled antibody microarray. Mol Cell Proteomics 4: 1664-1672.
63. Oh SW, Moon JD, Lim HJ, Park SY, Kim T, et al. (2005) Calixarene derivative as a tool for highly sensitive detection and oriented immobilization of proteins in a microarray format through noncovalent molecular interaction. FASEB J 19: 1335-1337.
64. Weng S, Gu K, Hammond PW, Lohse P, Rise C, et al. (2002) Generating addressable protein microarrays with PROfusion covalent mRNA-protein fusion technology. Proteomics 2: 48-57.
65. Kusnezow W, Hoheisel JD (2002) Antibody microarrays: Promises and problems. BioTechniques 33: S14-S23.
66. Pavlickova P, Knappik A, Kambhampati D, Ortigao F, Hug H (2003) Microarray of recombinant antibodies using a streptavidin sensor surface self-assembled onto a gold layer. BioTechniques 34: 124-130.
67. Knezevic V, Leethanakul C, Bichsel VE, Worth JM, Prabhu VV, et al. (2001) Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics 1: 1271-1278.
68. Gao WM, Kuick R, Orchekowski RP, Misek DE, Qiu J, et al. (2005) Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis. BMC Cancer 5: 110.
69. Bartling B, Hofmann HS, Boettger T, Hansen G, Burdach S, et al. (2005) Comparative application of antibody and gene array for expression profiling inhuman squamous cell lung carcinoma. Lung Cancer 49: 145-154.
70. Klysik J (2001) Concept of immunomics: A new frontier in the battle for gene function? Acta Biotheor 49: 191-202.
71. Anderson L, Seilhamer J (1997) A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18: 533-537.
72. Haab BB, Geierstanger BH, Michailidis G, Vitzthum F, Forrester S (2005) Immunoassay and antibody microarray analysis of the HUPO Plasma Proteome Project reference specimens: Systematic variation between sample types and calibration of mass spectrometry data. Proteomics 5: 3278-3291.
73. Belov L, Huang P, Chrisp JS, Mulligan SP, Christopherson RI (2005) Screening microarrays of novel monoclonal antibodies for binding to T-, B- and myeloid leukaemia cells. J Immunol Methods 305: 10-19.
74. Haab BB, Maitreya J, Dunham J, Brown PO (2001) Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol 2: 0004.1-0004.13.
75. Robinson WH, DiGennaro C, Hueber W, Haab BB, Kamachi M, et al. (2002) Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med 8: 295-301.
76. Feng Y, Ke X, Ma R, Chen Y, Hu G, et al. (2004) Parallel detection of autoantibodies with microarrays in rheumatoid diseases. Clin Chem 50: 416-422.
77. Hueber W, Kidd BA, Tomooka BH, Lee BJ, Bruce B, et al. (2005) Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum 52: 2645-2655.
78. Quintana FJ, Getz G, Hed G, Domany E, Cohen IR (2003) Cluster analysis of human autoantibody reactivities in health and in type 1 diabetes mellitus: A bio-informatic approach to immune complexity. J Autoimmun 21: 65-75.
79. Balboni I, Chan SM, Kattah M, Tenenbaum JD, Butte AJ, et al. (2006) Multiplexed protein array platforms for analysis of autoimmune diseases. Annu Rev Immunol 24: 391-418.
80. Shreffler WG, Beyer K, Chu TH, Burks AW, Sampson HA (2004) Microarray immunoassay: Association of clinical history, in vitro IgE function, and heterogeneity of allergenic peanut epitopes. J Allergy Clin Immunol 113: 776-782.
81. Schroeder CM, Ott H, Merk HF, Baron JM (2004) Aachen atopy array: A novel allergen chip technique for the analysis of serum IgE antibodies to recombinant latex allergens. J Allergy Clin Immunol 113: S329.
82. Sampson HA (2005) Food allergy - Accurately identifying clinical reactivity. Allergy 60: 19-24.
83. Shreffler WG, Lencer DA, Bardina L, Sampson HA (2005) IgE and IgG(4) epitope mapping by microarray immunoassay reveals the diversity of immune response to the peanut allergen, Ara h 2. J Allergy Clin Immunol 116: 893-899.
84. Alcocer MJC, Murtagh GJ, Wilson PB, Progias P, Lin J, et al. (2004) The major human structural IgE epitope of the Brazil nut allergen Ber e 1: A chimaeric and protein microarray approach. J Mol Biol 343: 759-769.
85. Deinhofer K, Sevcik H, Balic N, Harwanegg C, Hiller R, et al. (2004) Microarrayed allergens for IgE profiling. Methods 32: 249-254.
86. Reineke U, Ivascu C, Schlief M, Landgraf C, Gericke S, et al. (2002) Identification of distinct antibody epitopes and mimotopes from a peptide array of 5520 randomly generated sequences. J Immunol Methods 267: 37-51.
87. Chiari M, Cretich M, Corti A, Damin F, Pirri G, et al. (2005) Peptide microarrays for the characterization of antigenic regions of human chromogranin A. Proteomics 5: 3600-3603.
88. Chen Z, Pei D, Jiang L, Song Y, Wang J, et al. (2004) Antigenicity analysis of different regions of the severe acute respiratory syndrome coronavirus nucleocapsid protein. J Clin Chem 50: 988-995.
89. Davies DH, McCausland MM, Valdez C, Huynh D, Hernandez JE, et al. (2005) Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice. J Virol 79: 11724-11733.
90. Neuman de Vegvar HE, Amara RR, Steinman L, Utz PJ, Robinson HL, et al. (2003) Microarray profiling of antibody responses against simian-human immunodeficiency virus: postchallenge convergence of reactivities independent of host histocompatibility type and vaccine regimen. J Virol 77: 11125-11138.
91. Du H, Lu Y, Yang W, Wu M, Wang J, et al. (2004) Preparation of steroid antibodies and parallel detection of multianabolic steroid abuse with conjugated hapten microarray. Anal Chem 76: 6166-6171.
92. Knecht BG, Strasser A, Dietrich R, Märtlbauer E, Niessner R, et al. (2004) Automated microarray system for the simultaneous detection of antibiotics in milk. Anal Chem 76: 646-654.
93. Letarte M, Voulgaraki D, Hatherley D, Foster-Cuevas M, Saunders NJ (2005) Analysis of leukocyte membrane protein interactions using protein microarrays. BMC Biochemistry 6: 2.
94. Michaud GA, Salcius M, Zhou F, Bangham R, Bonin J, et al. (2003) Analyzing antibody specificity with whole proteomemicroarrays. Nat Biotechnol 21: 1509-1512.
95. Kemeny DM (1997) Enzyme-linked imunoassays. Immunochemistry 1: 147-175.
96. Copeland S, Siddiqui J, Remick D (2004) Direct comparison of traditional ELISAs and membrane protein arrays for detection and quantification of human cytokines. J Immunol Methods 284: 99-106.
97. Varnum SM, Woodbury RL, Zangar RC (2004) A protein microarray ELISA for screening biological fluids. J Methods Mol Biol 264: 161-172.
98. Pang S, Smith J, Onley D, Reeve J, Walker M, et al. (2005) A comparability study of the emerging protein array platforms with established ELISA procedures. J Immunol Methods 302: 1-12.
99. Slansky JE (2003) Antigen-specific T cells: Analyses of the needles in the haystack. PLoS Biol 1: 329-331. DOI: 10.1371/journal.pbio.0000078
100. Oelke M, Maus MV, Didiano D, June CH, Andreas M, et al. (2003) Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells. Nat Med 9: 619-625.
101. Czerkinsky C, Moldoveanu Z, Meztecky J, Nilson LA, Ouchterlony O (1988) A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells. J Immunol Methods 115: 31-37.
102. Segel L (2001) Controlling the immune system: Diffuse feedback via a diffuse informational network. Novartis Found Symp 239: 31-39.
103. Mills KHG (2004) Regulatory T cells: Friend or foe in immnunity to infection? Nat Rev Immunol 4: 841-855.
104. Chen DS, Soen Y, Stuge TB, Lee PP, Weber JS, et al. (2005) Marked differences in human melanoma antigen-specific T cell responsiveness after vaccination using a functional microarray. PLoS Med 2: DOI: 10.1371/journal. pmed.0020265
105. Landgrebe DA (2002) Hyperspectral image data analysis as a high dimensional signal processing problem. IEEE Signal Process 19: 17-28.
106. Devroye L, Györfi L, Lugosi G (1996) A probabilistic theory of pattern recognition. New York: Springer. 636 p.
107. Chen J, Dougherty ER, Demir S, Friedman C, Sheng Li C, et al. (2005) Grand challenges for multimodal bio-medical systems. IEEE Circuits Syst Spring: 46-52.
108. Kauffman S (1993) The origins of order: Self-organization and selection in evolution. New York: Oxford University Press. 709 p.
109. Athanassikis I, Vassiliadis S (2002) T-regulatory cells: Are we rediscovering T suppressors? Immunol Lett 84: 179-183.
110. + Treg: Divide, rule? Immunology 111: 129-137.
111. Wraith DC, Nicolson KS, Whitley NT (2004) Regulatory CD4 T cells and the control of autoimmune diseases. Curr Opin Immunol 16: 695-701.
112. de Jong H (2002) Modeling and simulation of genetic regulatory systems: A literature review. J Comput Biol 9: 67-103.
113. Huang S (1999) Gene expression profiling, genetic networks, and cellular states: An integrating approach for tumorigenesis and drug discovery. J Mol Med 77: 469-480.
114. Popper K (1959) The logic of scientific discovery. London: Hutchinson. 513 p.
115. Dougherty ER, Braga-Neto U (2006) Epistemology of computational biology: Mathematical models and experimental prediction as the basis of their validity. J Biol Syst 14: 1-26.
116. Chao DL, Davenport MP, Forrest S, Perelson AS (2004) A stochastic model of cytotoxic T cell responses. J Theoret Biol 228: 227-240.
117. Segel L (2000) Diffuse feedback from diffuse information in complex systems. Complexity 5: 39-46.
118. Schonbach C (2003) From immunogenetics to immunomics: Functional prospecting of genes and transcripts. Novartis Found Symp 254: 177-188.